1. A comprehensive review of epidemiology, virology, and prevention for COVID-19 and its variants<br>2. Coronavirus Disease 2019 and the SARS-CoV-2 variants: Virological perspectives<br>3. Introduction to antiviral nanomaterials: Mechanisms and applications<br>4. An overview of antiviral nanomedicine: Types, structures and functions<br>5. Nanotechnology-based strategies for combating coronavirus<br>6. Nanotechnology for diagnosis of COVID-19: Current achievements and future directions<br>7. Nanomaterial-based therapeutic drugs for SARS-CoV-2 variants: Recent finding, limitations, and prospects<br>8. The development of lipid nanoparticle technology for the management of COVID-19<br>9. Nanotechnology for the prevention of SARS-CoV-2 infection<br>10. Nanotechnology-assisted therapeutic antibodies against SARS-CoV-2 variants: Current findings and future perspectives<br>11. COVID-19 drug delivery: Current achievements and the impact of nanocarriers<br>12. Nanotechnology-based drug delivery for combating SARS-CoV-2 variants<br>13. An overview of COVID-19 vaccine development: Highlighting the role of nanotechnology<br>14. Nanotechnology-based vaccine development for COVID-19<br>15. An updated overview of clinical trials, official approval, and risks for the application of nanomaterials in COVID-19 management<br>16. Anti-SARS-CoV-2 nanoparticles: Mechanisms and applications<br>17. Engineered nanoparticles for the management of COVID-19 and new variants of SARS-CoV-2<br>18. Nature’s arsenal: Combatting SARS-CoV-2 variants with phytocompound nanoparticles<br>19. Emerging nanomaterials for COVID-19 therapeutics<br>20. Metallic nanoparticles-based strategies for COVID-19 management in the post-pandemic era<br>21.. Nanotechnological Approaches for COVID-19 Management: Highlighting the Impact on SARS-Co-V-2 Variants<br>22. Advancing Pandemic Response: The Impact of Nanodiagnostics on COVID-19 and Other Infectious Diseases
